BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 16770320)

  • 1. AM404, an inhibitor of anandamide uptake, prevents pain behaviour and modulates cytokine and apoptotic pathways in a rat model of neuropathic pain.
    Costa B; Siniscalco D; Trovato AE; Comelli F; Sotgiu ML; Colleoni M; Maione S; Rossi F; Giagnoni G
    Br J Pharmacol; 2006 Aug; 148(7):1022-32. PubMed ID: 16770320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Actions of the endocannabinoid transport inhibitor AM404 in neuropathic and inflammatory pain models.
    Mitchell VA; Greenwood R; Jayamanne A; Vaughan CW
    Clin Exp Pharmacol Physiol; 2007 Nov; 34(11):1186-90. PubMed ID: 17880375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AM404, an inhibitor of anandamide reuptake decreases Fos-immunoreactivity in the spinal cord of neuropathic rats after non-noxious stimulation.
    Rodella LF; Borsani E; Rezzani R; Ricci F; Buffoli B; Bianchi R
    Eur J Pharmacol; 2005 Jan; 508(1-3):139-46. PubMed ID: 15680264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The anandamide transport inhibitor AM404 reduces ethanol self-administration.
    Cippitelli A; Bilbao A; Gorriti MA; Navarro M; Massi M; Piomelli D; Ciccocioppo R; Rodríguez de Fonseca F
    Eur J Neurosci; 2007 Jul; 26(2):476-86. PubMed ID: 17650118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peripheral antinociceptive effect of anandamide and drugs that affect the endocannabinoid system on the formalin test in normal and streptozotocin-diabetic rats.
    Schreiber AK; Neufeld M; Jesus CH; Cunha JM
    Neuropharmacology; 2012 Dec; 63(8):1286-97. PubMed ID: 22959964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AM404 decreases Fos-immunoreactivity in the spinal cord in a model of inflammatory pain.
    Borsani E; Labanca M; Bianchi R; Rodella LF
    Brain Res; 2007 Jun; 1152():87-94. PubMed ID: 17459353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anxiolytic-like properties of the anandamide transport inhibitor AM404.
    Bortolato M; Campolongo P; Mangieri RA; Scattoni ML; Frau R; Trezza V; La Rana G; Russo R; Calignano A; Gessa GL; Cuomo V; Piomelli D
    Neuropsychopharmacology; 2006 Dec; 31(12):2652-9. PubMed ID: 16541083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of neuropathic and inflammatory pain by the endocannabinoid transport inhibitor AM404 [N-(4-hydroxyphenyl)-eicosa-5,8,11,14-tetraenamide].
    La Rana G; Russo R; Campolongo P; Bortolato M; Mangieri RA; Cuomo V; Iacono A; Raso GM; Meli R; Piomelli D; Calignano A
    J Pharmacol Exp Ther; 2006 Jun; 317(3):1365-71. PubMed ID: 16510698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitory effect of intrathecally administered AM404, an endocannabinoid reuptake inhibitor, on neuropathic pain in a rat chronic constriction injury model.
    Haranishi Y; Hara K; Terada T
    Pharmacol Rep; 2021 Jun; 73(3):820-827. PubMed ID: 33783763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversal of dopamine D(2) receptor responses by an anandamide transport inhibitor.
    Beltramo M; de Fonseca FR; Navarro M; Calignano A; Gorriti MA; Grammatikopoulos G; Sadile AG; Giuffrida A; Piomelli D
    J Neurosci; 2000 May; 20(9):3401-7. PubMed ID: 10777802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased endocannabinoid levels in the brain and beneficial effects of agents activating cannabinoid and/or vanilloid receptors in a rat model of multiple sclerosis.
    Cabranes A; Venderova K; de Lago E; Fezza F; Sánchez A; Mestre L; Valenti M; García-Merino A; Ramos JA; Di Marzo V; Fernández-Ruiz J
    Neurobiol Dis; 2005 Nov; 20(2):207-17. PubMed ID: 16242629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Divergent effects of anandamide transporter inhibitors with different target selectivity on social play behavior in adolescent rats.
    Trezza V; Vanderschuren LJ
    J Pharmacol Exp Ther; 2009 Jan; 328(1):343-50. PubMed ID: 18948500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anandamide transport inhibitor AM404 and structurally related compounds inhibit synaptic transmission between rat hippocampal neurons in culture independent of cannabinoid CB1 receptors.
    Kelley BG; Thayer SA
    Eur J Pharmacol; 2004 Aug; 496(1-3):33-9. PubMed ID: 15288572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuropathic pain and the endocannabinoid system in the dorsal raphe: pharmacological treatment and interactions with the serotonergic system.
    Palazzo E; de Novellis V; Petrosino S; Marabese I; Vita D; Giordano C; Di Marzo V; Mangoni GS; Rossi F; Maione S
    Eur J Neurosci; 2006 Oct; 24(7):2011-20. PubMed ID: 17040473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Augmentation of endogenous cannabinoid tone modulates lipopolysaccharide-induced alterations in circulating cytokine levels in rats.
    Roche M; Kelly JP; O'Driscoll M; Finn DP
    Immunology; 2008 Oct; 125(2):263-71. PubMed ID: 18393970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of anandamide uptake inhibition in the production of nitric oxide and in the release of cytokines in astrocyte cultures.
    Ortega-Gutiérrez S; Molina-Holgado E; Guaza C
    Glia; 2005 Nov; 52(2):163-8. PubMed ID: 15920730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AM404 and VDM 11 non-specifically inhibit C6 glioma cell proliferation at concentrations used to block the cellular accumulation of the endocannabinoid anandamide.
    Jonsson KO; Andersson A; Jacobsson SO; Vandevoorde S; Lambert DM; Fowler CJ
    Arch Toxicol; 2003 Apr; 77(4):201-7. PubMed ID: 12698235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of the cannabinoid CB1 receptor antagonist, SR141716, on nociceptive response and nerve demyelination in rodents with chronic constriction injury of the sciatic nerve.
    Costa B; Trovato AE; Colleoni M; Giagnoni G; Zarini E; Croci T
    Pain; 2005 Jul; 116(1-2):52-61. PubMed ID: 15936882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Triptolide prevents and attenuates neuropathic pain via inhibiting central immune response.
    Wang W; Mei XP; Chen L; Tang J; Li JL; Wu SX; Xu LX; Li YQ
    Pain Physician; 2012; 15(6):E995-1006. PubMed ID: 23159984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated circulating levels of anandamide after administration of the transport inhibitor, AM404.
    Giuffrida A; Rodriguez de Fonseca F; Nava F; Loubet-Lescoulié P; Piomelli D
    Eur J Pharmacol; 2000 Nov; 408(2):161-8. PubMed ID: 11080522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.